Clinical Inhibition of CYP2D6-catalysed Metabolism by the Antianginal Agent Perhexiline
British Journal of Clinical Pharmacology - United Kingdom
doi 10.1046/j.1365-2125.2003.02033.x
Full Text
Open PDFAbstract
Available in full text
Categories
Date
January 7, 2004
Authors
Publisher
Wiley